2015-08-05 12:18:29 UTC

Just Released: 2016 Excluded Drugs Lists

Aug. 11, 2015

Take a look at the GI-related drugs included in next year's lists of excluded or limited medications from two pharmacy benefit managers.

Express Scripts and CVS Caremark, the two largest pharmacy benefit managers, recently released their lists of medications that will be excluded from insurance coverage in 2016. 

The Express Scripts list of excluded drugs includes the following GI-related drugs:

  • Anti-inflammatory/anti-ulcer agents: Vimovo and Duexis.
  • Inflammatory bowel agents: Asacol HD, Delzicol and Dipentum.
  • Pancreatic enzymes: Pancreaze, Pertzye and Ultresa.
  • HCV treatments: Harvoni, Olysio and Sovaldi. 

CVS Caremark’s list of GI-related drugs excludes:

  • HCV treatements: excludes Viekira Pak, prefers Harvoni and doesn't mention Sovaldi
  • IBS agents: Amitiza.
  • Opioid-induced constipation agents: Relistor.
  • PPIs: Prevacid and Protoni. 

Visit Express Scripts and CVS Caremark for the complete lists of excluded drugs and preferred alternatives.

More on Chronic Pancreatitis

Early Treatment Decisions Can Alter the Course of Care for Acute Pancreatitis Patients

Feb. 8, 2018

New AGA evidence-based clinical guideline helps GIs better manage the condition

Better Manage Acute Pancreatitis to Improve Patient Outcomes

Feb. 7, 2018

New AGA guideline addresses questions on the benefits of goal directed fluid resuscitation, early oral feeding and more.

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.